1/199
Comprehensive set of 200 vocabulary flashcards covering Module 6 on Good Laboratory Practice (GLP), the OECD framework, facility roles, study documentation, and compliance monitoring systems.
Module 6
The specific instructional module within RAPM58619 dedicated to the principles and implementation of Good Laboratory Practice (GLP).
RAPM58619
The course code designated for Principles of Good Practices GxP, covering OECD Good Laboratory Practice and compliance monitoring systems.
Good Laboratory Practice (GLP)
The organizational process and conditions under which non-clinical health and environmental safety studies are planned, performed, monitored, recorded, archived, and reported.
Non-Clinical Studies
Experiments conducted under laboratory conditions to determine the safety or tolerability of test items, excluding studies utilizing human subjects or clinical studies in animals.
Tolerability
A primary parameter evaluated in non-clinical laboratory experiments to assess how well a biological test system sustains exposure to a test item without excessive adverse effects.
Safety (in Non-Clinical Testing)
The hazard and risk profile determined through controlled laboratory, greenhouse, or field non-clinical studies under GLP.
Clinical Studies
Investigations involving human subjects or clinical studies in animals, which are explicitly excluded from the scope of OECD GLP Principles.
Organization for Economic Cooperation and Development (OECD)
An international organization comprising 38 member countries and 5 partners that establishes international standards and fosters collaboration on global issues.
Organization for European Economic Co-operation (OECC)
The predecessor body to the OECD, founded in 1948 to administer economic aid following World War II.
1948 (OECC Founding)
The year the Organization for European Economic Co-operation (OECC) was established to administer aid after WWII.
1962 (OECD Transition)
The year the Organization for European Economic Co-operation (OECC) officially transitioned and became the OECD.
OECD Member Countries
The 38 sovereign nations, including Canada, that comprise the OECD and agree to uphold its established international guidelines.
OECD Partner Countries
The 5 global partner economies that collaborate with the OECD on international standards and policy initiatives alongside member nations.
Inform & Advise
An OECD main function focused on providing socio-economic data and analytical insights to policy makers and researchers.
Engage & Influence
An OECD main function that brings policy makers and policy experts together to exchange ideas and develop public policies.
Set Standards and Provide Policy Support
An OECD main function dedicated to developing internationally agreed standards to ensure all member nations adhere to similar rules.
Socio-Economic Data and Analysis
Quantitative and qualitative research compiled under the OECD's 'Inform & Advise' mandate to guide policy decisions.
1981 (OECD GLP Adoption)
The year the Principles of Good Laboratory Practice were formally adopted by the OECD Council, with participation from countries including Canada.
Harmonization of Test Methods
The international alignment of testing protocols and GLP principles to prevent duplicative animal and chemical safety testing across nations.
Duplicative Testing
Redundant safety testing carried out in multiple jurisdictions, which OECD GLP harmonization aims to eliminate.
Mutual Acceptance of Data (MAD)
The OECD principle establishing that non-clinical safety data generated in an OECD member state in accordance with GLP will be accepted by other member countries.
1997 (Revised GLP Adoption)
The year the OECD Council formally adopted the updated and Revised Principles of Good Laboratory Practice.
OECD Document No. 1
The official document in the OECD Series on Principles of GLP and Compliance Monitoring titled 'OECD Principles on Good Laboratory Practice' (env/mc/chem(98)17).
OECD Document No. 2
The official document in the OECD Series on Principles of GLP and Compliance Monitoring titled 'Revised Guides for Compliance Monitoring Procedures for Good Laboratory Practice' (ocde/gd(95)66).
Non-Clinical Safety Studies
Controlled experimental evaluations carried out by test facilities to evaluate the health and environmental safety profiles of regulated items.
Pharmaceutical Products (GLP Scope)
Human medicinal drug products whose non-clinical safety and tolerability testing must be conducted in compliance with GLP.
Pesticide Products (GLP Scope)
Agrochemical and pest control substances whose non-clinical safety data must be generated in adherence to GLP standards.
Cosmetic Products (GLP Scope)
Personal care and cosmetic substances whose non-clinical safety evaluations fall under the regulatory applicability of GLP.
Veterinary Drugs (GLP Scope)
Therapeutic products intended for animal administration that require non-clinical safety studies executed following GLP.
Food and Feed Additives (GLP Scope)
Direct substances or supplements introduced into food or animal feed that require GLP-compliant non-clinical safety testing.
Industrial Chemicals (GLP Scope)
Commercial chemical agents and bulk substances whose health and environmental safety data must be established under GLP.
Greenhouses (GLP Testing Site)
Enclosed, controlled plant growth environments recognized under GLP as valid testing locations for non-clinical studies.
Field Studies (GLP Testing Site)
Outdoor or agricultural experimental environments outside traditional laboratories where non-clinical safety studies are conducted under GLP.
Test Facility
The organizational entity encompassing personnel, premises, and operational units required for carrying out non-clinical safety studies.
Test Facility Management
The person or persons having the formal authority and responsibility for the organization and functioning of the test facility.
Formal Responsibility and Authority (Management)
The executive mandate vested in test facility management to direct operations, allocate resources, and ensure total GLP compliance.
Personnel Sufficiency
The requirement that test facility management ensure a sufficient number of personnel are available to perform all study functions.
Personnel Qualifications and Training Records
Curated files maintained by management containing records of qualifications, training, experience, and job descriptions for all facility staff.
Job Description (GLP)
A documented outline maintained for each individual in a test facility specifying their defined functions, roles, and responsibilities.
Facility Resource Allocation
The management duty to ensure that appropriate facilities, equipment, and materials are available for the conduct of studies.
Documented Study Plan Approval (Management Duty)
A key management responsibility to ensure that the study plan receives formal, documented approval by the Study Director prior to study initiation.
Master Schedule
A comprehensive tracking system maintained by test facility management to compile study timelines, track active studies, and assess facility workload.
Master Schedule Maintenance
The active administrative responsibility of test facility management to keep the central schedule of all studies up to date.
Test and Reference Items Inventory
A documented management system ensuring that test and reference items are appropriately logged, tracked, and stored within the facility.
Computer Systems Suitability
The management requirement ensuring that all computer systems used in non-clinical studies are appropriate and fit for their intended purpose.
Computer Systems Validation
The documented process established by management to ensure computer systems operate reliably, accurately, and in compliance with GLP.
Computer Systems Operation and Maintenance
Procedures established by management ensuring computer systems are operated and maintained in strict accordance with GLP.
Standard Operating Procedures (SOPs)
Written, management-approved procedures outlining how routine laboratory, administrative, and testing operations must be executed.
Approval of Original SOPs
The formal responsibility of test facility management to evaluate, approve, and sign all newly created Standard Operating Procedures.
Approval of Revised SOPs
The mandatory endorsement required from test facility management to validate any changes or updates made to existing SOPs.
Study Director
The single point of study control who has the responsibility for the overall conduct of the study and for its final report.
Single Point of Study Control
The regulatory concept designating the Study Director as the central individual with sole responsibility for the entire study.
Overall Conduct of the Study
The technical, scientific, and administrative execution of a non-clinical study, which falls entirely under the Study Director's accountability.
Final Report Responsibility (Study Director)
The obligation of the Study Director to oversee, compile, validate, sign, and date the final study report.
Study Plan Approval (Study Director)
The formal signing and dating of the written study plan by the Study Director prior to starting experimental activities.
Study Plan Amendments Approval
The Study Director's duty to formally review, justify, approve, and sign any modifications made to an approved study plan.
Communication with Quality Assurance (Study Director)
The requirement for the Study Director to communicate effectively with QA personnel and ensure they possess an approved copy of the study plan.
SOP Availability (Study Director Duty)
The Study Director's responsibility to make all approved study plans and relevant SOPs readily accessible to study personnel.
Multi-Site Study
A study conducted across multiple test facilities or test sites, requiring coordination between the Study Director and Principal Investigators.
Test Site
A distinct location or external facility where specific delegated phases of a multi-site study are performed.
Principal Investigator (PI)
An individual who, for a multi-site study, acts on behalf of the Study Director and has defined responsibilities for delegated phases of the study.
Delegated Phases of the Study
Specific experimental, operational, or analytical segments of a multi-site study assigned to a Principal Investigator at a remote test site.
Non-Delegable Responsibilities (Study Director)
Core duties that cannot be delegated to a PI, including approval of study plans/amendments, signing final reports, and overall GLP compliance.
Study Plan Adherence (Study Director)
The Study Director's duty to verify that all study personnel follow the approved study plan throughout the study.
Assessment of Study Plan Deviations
The scientific evaluation conducted by the Study Director to determine how unintended departures from the protocol affect study validity.
Documentation of Deviations (Study Director)
The formal recording and explanation of any deviations from the study plan performed by the Study Director.
Corrective Actions (Study Director)
Remedial procedures designed and implemented by the Study Director to correct study plan deviations when necessary.
Raw Data Recording (Study Director Duty)
The Study Director's obligation to ensure that all raw data generated during an experiment is fully recorded and documented.
Computerized Systems Validation Verification (Study Director)
The Study Director's responsibility to confirm that all computerized systems utilized during the study have been validated.
Final Report Sign-Off (Study Director)
The requirement that the Study Director sign and date the final report to indicate the validity of the data.
Indication of GLP Compliance Extent
A formal statement signed by the Study Director in the final report declaring the extent to which the study complies with GLP.
Post-Study Archiving (Study Director Duty)
The Study Director's responsibility to archive the study plan, final report, raw data, and supporting material after study completion.
Supporting Material Archiving
The secure transfer and preservation of physical specimens, samples, and documentation to the facility archives following study completion.
Principal Investigator GLP Compliance
The duty of a Principal Investigator to ensure that all delegated phases of a multi-site study under their supervision comply with GLP.
Study Personnel
Laboratory technicians, scientists, and operational staff directly engaged in executing the procedures of a non-clinical study.
Study Personnel SOP Compliance
The obligation of technical staff to comply strictly with all applicable study plans and Standard Operating Procedures.
Personnel Deviation Communication
The mandatory requirement that study personnel document deviations and communicate them immediately to the Study Director or PI.
Prompt Raw Data Recording
The GLP requirement that study personnel record raw experimental observations promptly at the time of execution.
Accurate Raw Data Recording
The obligation of study personnel to document laboratory data accurately, completely, and in accordance with GLP.
Health Precautions (Study Personnel)
Protective measures and occupational hygiene protocols taken by study personnel to minimize risks and ensure study integrity.
Health and Medical Condition Reporting
The requirement that study personnel communicate any relevant health or medical condition that could compromise the study.
Study Integrity
The complete scientific validity, authenticity, and untainted status of experimental results and biological systems in a study.
Quality Assurance (QA) Program
A documented program required to assure that non-clinical studies are performed in compliance with GLP.
Documented QA Program
Written policies, inspection procedures, and audit schedules defining the operational execution of Quality Assurance in a facility.
Quality Assurance Personnel
Personnel familiar with test procedures who are designated by and directly responsible to management to monitor GLP compliance.
QA Familiarity with Test Procedures
The prerequisite technical knowledge Quality Assurance personnel must possess regarding test methods to audit studies effectively.
Direct Responsibility to Management (QA)
The reporting structure whereby Quality Assurance personnel report directly to facility management rather than study staff.
QA Independence from Study Conduct
The GLP rule establishing that Quality Assurance personnel should not be involved in the actual conduct of the study.
QA Access to Master Schedule
The entitlement and operational requirement for QA personnel to maintain access to the facility master schedule.
Study Plan GLP Verification (QA)
The formal review conducted by QA personnel to verify and document that a written study plan complies with GLP principles.
Study Inspections (QA)
Periodic examinations performed by QA personnel to verify that study conduct and facility operations comply with GLP.
Retention of Inspection Records (QA)
The mandatory preservation of audit logs, findings, and checklists generated by QA personnel during facility and study inspections.
Prompt Reporting of Inspection Results (QA)
The requirement that QA personnel promptly report all inspection findings in writing to management and the Study Director.
QA Statement (Final Report)
A formal statement prepared and signed by QA for the final report detailing inspection information, inspection dates, and data verification.
QA Inspection Dates Reporting
Detailed calendar information on all study inspections that QA personnel must include within the final report's QA statement.
Review of Final Reports (QA)
The Quality Assurance audit verifying that the final report accurately and completely reflects the study raw data.
Facility Size, Construction, and Location
Physical requirements mandating that test facilities have a suitable size, construction, and location to meet the requirements of the study.
Separation of Activities (Facilities)
The architectural provision of a sufficient number of rooms or areas to separate distinct activities and prevent mix-ups.
Biohazardous Substances Isolation
The structural isolation of facility rooms and test systems involving biohazardous substances to prevent contamination.
Storage Rooms for Supplies and Equipment
Dedicated rooms or areas within a test facility allocated for the secure storage of operational supplies and equipment.